Managing Ulcerative Colitis – The Guidelines and Beyond

European Medical Journal Gastroenterology

Mitchell RKL Lie¹  C Janneke van der Woude¹ 

[1] Department of Gastroenterology, Erasmus University Hospital, Rotterdam, the Netherlands;

关键词: 5-ASA;    6-mercaptopurine;    6-thioguanine;    Adalimumab;    Azathioprine;    Corticosteroids;    Cyclosporine;    Golimumab;    Infliximab;    Management;    Methotrexate;    Mycophenolate Mofetil;    Tacrolimus;    Therapy;    Ulcerative Colitis;    Vedolizumab;   

DOI  :  

来源: DOAJ

【 摘 要 】

Management guidelines offer clinicians clear, evidence-based and often succinct treatment advice. For ulcerative colitis these guidelines describe the use of 5-ASA, corticosteroids, thiopurines, cyclosporine, and anti-TNFα therapies. However, guidelines do have some drawbacks, mainly a lack of concrete advice concerning patients resistant to these aforementioned therapies. This review gives a short overview of current guidelines and addresses treatment alternatives for conventional therapies.

【 授权许可】

Unknown